Crossmark

Biologically-derived nanoparticles for chemo-ferroptosis combination therapy

Crossref DOI link: https://doi.org/10.1039/D1QM00295C

Published Online: 2021

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Sun, Haifeng https://orcid.org/0000-0002-3496-8103
Zhang, Zhonghe

Kang, Xiaoyu

Dai, Qiong https://orcid.org/0000-0003-1510-6054
Song, Aixin https://orcid.org/0000-0001-9766-1742
Hao, Jingcheng https://orcid.org/0000-0002-9760-9677
Cui, Jiwei https://orcid.org/0000-0003-1018-4336
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (21802088, 21872085)

Shandong Province (2020KJC001)
License Information

Accepted Manuscript valid from 2022-03-25
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

RELATED DATA

: Supplementary Information

IDENTIFIERS

: Haifeng Sun (ORCID)

: Qiong Dai (ORCID)

: Aixin Song (ORCID)

: Jingcheng Hao (ORCID)

: Jiwei Cui (ORCID)

: Jiwei Cui (ResearcherID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 22 February 2021; Accepted 14 March 2021; Accepted Manuscript published 25 March 2021; Advance Article published 14 April 2021; Version of Record published 18 May 2021